Live News EQUITY FLASH L impact Oct 27, 2026, 01:24 PM UTC AbbVie Seeks FDA Approval for Etentamig AbbVie filed a biologics license application for etentamig, seeking FDA approval for multiple myeloma. ABBV SquawkNews Desk